medigraphic.com
ISSN 1405-8871 (Print)

2019, Number 1

<< Back Next >>

Aten Fam 2019; 26 (1)

Lifestyle Impact on Glycemic Decontrol in Patients with type 2 Diabetes Mellitus

Vásquez ASB, Roy GIA, Velázquez LL, Navarro SLG

Language: Spanish
References: 27
Page: 18-22
PDF size: 139.82 Kb.


ABSTRACT

Objective: To determine the impact of lifestyle and its different components on glycemic control of patients with Diabetes Mellitus type 2 (dm2). Methods: Analytical and cross-sectional design, the study was conducted in a Family Medicine Unit in Mexico City from August to October 2015. 330 participants with dm2 were included, from 20 to 60 years under pharmacological treatment. The Instrument to Measure Lifestyle in Diabetes (Imevid) was used. To measure glycemic control, glycosylated hemoglobin (HbA1c) was used, if Hb1Ac was ‹7% it was considered to be glycemic control. To know the risk factors associated with glycemic decontrol, a multiple logistic regression model was performed, which was adjusted according to lifestyle, comorbidities, dm2 evolution time, and body mass index (bmi). Results: 70.3% (232) of the participants were in a group where age was between 51 to 60 years, 90.6% (299) presented some comorbidity, systemic arterial hypertension was the most frequent. 48.8% (161) presented overweight and 14.8% (49) obesity. 35.8% (118) presented a good lifestyle, 43.9% (145) had glycemic control. The media Hb1Ac in poor lifestyle patients was 9% compared to the good lifestyle group with 6.4% (p ‹0.001). Good lifestyle is a protective factor for glycemic control with an odds ratio (or) of 0.026. Conclusions: unhealthy lifestyle is a risk factor for glycemic decontrol. Lifestyle, comorbidities, dm2 time of evolution and bmi explain the 85.3% of glycemic decontrol.


REFERENCES

  1. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Informe Final de Resultados. [Internet] 2016 [Citado 2017 Dic 12]. Disponible en: https://www.gob.mx/cms/uploads/attachment/ file/209093/ENSANUT.pdf

  2. Rojas MR, Basto AA, Aguilar SC, Zárate RE, Villalpando S, Barrientos GT. Prevalencia de diabetes por diagnóstico médico previo en México. Salud Pública Mex. 2018;60:224-32.

  3. Escobedo DJ, Buitrón GL, Ramírez MJ, Chavira MR, Schargrodsky H, Marcet Champagne B. Diabetes en México. Estudio carmela Cir. 2011;79(5):424-431.

  4. Kheirandish M, Mahboobi H, Yazdanparast M, Kamal MA. Challenges Related to Glycemic Control in Type 2 Diabetes Mellitus Patients. Curr Drug Metab. 2017;18(2):157-162.

  5. Zhen Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017;14:88- 98.

  6. Mendez HP, Flores P, Siani C, Lamure M, Dosamantes CL, Halley CE, y cols. Physical activity and risk of Metabolic Syndrome in an urban Mexican cohort. bmc Public Health. 2009;9:276.

  7. Resendiz R. Ocampo A. Saldierna A. Asociación de los dominios (estilo de vida) de la encuesta Imevid, con glucemia, en pacientes con diabetes tipo 2. Rev Sanid Milit Mex. 2010;64(5):211- 223.

  8. Rodríguez GR, Montori VM. Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence. Circ Cardiovasc Qual Outcomes. 2016;9(5):504-512.

  9. Hernández M. Gutiérrez. J. Encuesta Nacional de Salud y nutrición. Evidencia para la política pública en salud. Diabetes mellitus: la urgencia de reforzar la respuesta en políticas públicas para su prevención y control. Salud Púb Méx. [Internet] 2012 [Citado 2017 Nov 7]. Disponible en: http://ensanut.insp. mx/doctos/analiticos/DiabetesMellitus.pdf

  10. González A. Elizondo S. Torres I, Rangel M. Ramírez M. Jiménez N. Control glucémico en pacientes ambulatorios con diabetes en la consulta externa del Hospital General de México. Rev Med Hosp Gen Méx. 2010;73:161-165.

  11. Urbán RB, Coghlan LJ, Castañeda SO. Estilo de vida y control glucémico en pacientes con Diabetes Mellitus en el primer nivel de atención. Aten Fam. 2015;22(3):68-71.

  12. López J. Ariza C. Rodriguez J. Miranda C. Construcción y validación inicial de un instrumento para medir el estilo de vida en pacientes con diabetes tipo 2. Salud Púb Méx. 2003;45:259-268.

  13. Kayar Y, Ilhan A, Kayar NB, Unver N, Coban G, Ekinci I, and col. Relationship between the poor glycemic control and risk factors, life style and complications. Biomed Res. 2017;28(4);1581- 1586.

  14. Talavera JO, Rivas RR. Clinical research IV. Relevancy of the statistical test chosen. Rev Med Inst Mex Seguro Soc. 2011;49(4):401-405.

  15. Hudzik B, Korzonek SI, Szkodziński J, Gierlotka M, Lekston A, Zubelewicz-Szkodzińska B, et. al. Prognostic impact of multimorbidity in patients with type 2 diabetes and ST-elevation myocardial infarction. Oncotarget. 2017;8(61):67-77.

  16. Leitner DR, Frühbeck G, Yumuk V, Schindler K, Micic D, Woodward E, y cols. Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way. Obes Facts. 2017;10:483-492.

  17. Van Gaal L, Scheen A. Weight management in type 2 diabetes: current and emerging approaches to treatment. Diabetes Care. 2015;38(6):1161-1172.

  18. Look ahead Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look ahead trial. Arch Intern Med. 2010;170(17):1566–1575.

  19. Noor SK, Elmadhoun WM, Bushara SO, Almobarak AO, et al. Glycaemic control in Sudanese individuals with type 2 diabetes: Population based study. Diabetes Metab Syndr. 2017;11(1):147- 151.

  20. Takahashi E, Moriyama K, Yamakado M; Ningen Dock Database Group. Lifestyle and glycemic control in Japanese adults receiving diabetes treatment: an analysis of the 2009 Japan Society of Ningen Dock database. Diabetes Res Clin Pract. 2014;104(2):50-53.

  21. Wagner KA, Armah SM, Smith LG, et al. Associations between Diet Behaviors and Measures of Glycemia, in Clinical Setting, in Obese Adolescents. Childhood Obesity. 2016;12(5):341-347.

  22. Velazquez Lopez, L, Muñoz Torres, A.V, Garcia Peña, C, Lopez Alarcon , M, Islas Andrade, S, et al. Fiber in diet is associated with improvement of glycated Hemoglobin and lipid profile in Mexican Patients with Type 2 Diabetes. J Diabetes Res. [Internet]. [Citado 2018 Mar 18]. Disponible en: http://dx.doi.org/10.1155/2016/2980406

  23. Psaltopoulou T, Ilias I, Alevizaki M. The Role of Diet and Lifestyle in Primary, Secondary, and Tertiary Diabetes Prevention: A Review of Meta- Analyses. Rev Diabet Stud. 2010;7(1):26-35.

  24. Kamuhabwa AR, Charles E. Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam. Drug Healthc Patient Saf. 2014; 6:155-65.

  25. Bains SS, Egede LE. Associations Between Health Literacy, Diabetes Knowledge, Self-Care Behaviors, and Glycemic Control in a Low Income Population with Type 2 Diabetes. Diabetes Technology & Therapeutics. 2011;13(3):335-341.

  26. Fernández VA, Abdala CTA, Alvara SEP, Tenorio FGL, López VE, Cruz CSD, y cols. Estrategias de autocuidado en pacientes con diabetes mellitus tipo 2. Rev Esp Méd Quir. 2012;17(2):94-99.

  27. León M. Araujo G. Linos Z. Diabetimss, Eficacia del programa de educación en diabetes en los parámetros clínicos y bioquímicos, Rev Med Inst Méx Seguro Soc. 2012;5:74-79. Vásquez Arroyo SB Aten. Fam. 2019;26(1):18-22. http://dx.doi.org/10.22201/facmed.14058871p.2019.1.67712




2020     |     www.medigraphic.com